Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.
about
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of CardiomyopathiesAssociation Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.Titin Truncating Variants in Dilated Cardiomyopathy - Prevalence and Genotype-Phenotype Correlations.Genetics and genomics of dilated cardiomyopathy and systolic heart failure.Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.Established and novel treatment options in acute myocarditis, with or without heart failure.Clinical impact of the presence of macrophages in endomyocardial biopsies of patients with dilated cardiomyopathy.Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC).Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease.Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge.Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.Insights into mildly dilated cardiomyopathy: temporal evolution and long-term prognosis.Myocarditis: A Clinical Overview.Animal models of arrhythmogenic right ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeutics.Shocks after implantable cardioverter-defibrillator implantation in idiopathic cardiomyopathy patients: a myocardial biopsy study.Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2.MicroRNA miR-301a is a novel cardiac regulator of Cofilin-2.Intercalated disc in failing hearts from patients with dilated cardiomyopathy: Its role in the depressed left ventricular function.Formation of a TBX20-CASZ1 protein complex is protective against dilated cardiomyopathy and critical for cardiac homeostasis.Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications.Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients.High proportion of genetic cases in patients with advanced cardiomyopathy including a novel homozygous Plakophilin 2-gene mutation.Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study.Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy.Clinical predictors of outcome in patients with inflammatory dilated cardiomyopathy.Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience.T2 mapping cardiovascular magnetic resonance identifies the presence of myocardial inflammation in patients with dilated cardiomyopathy as compared to endomyocardial biopsy.Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy.Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis.Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice.Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.Special issues in heart failure: pulmonary hypertension, deranged potassium levels, and haemodynamic profiles.Evolving concepts in dilated cardiomyopathy.Lost in markers? Time for phenomics and phenomapping in dilated cardiomyopathy.Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease.Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.Arrhythmia-Induced Cardiomyopathy.Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives.Exploring the Crosstalk Between and Splicing Machinery Gene Mutations in Dilated Cardiomyopathy
P2860
Q26738818-B5EDC279-FE6A-414A-9DFC-7EF96C8CA482Q33727302-D442524D-9807-456D-9971-E51323A1638EQ36238050-DA4ED3D4-AD1F-46AF-9CA1-9145EB0523FCQ37661546-3D28F948-646C-4ED0-A15E-7CD388F06DF9Q38659406-6E68617B-3845-42BA-ACD5-0F814D6C2519Q38794097-4C3B2F7E-55EA-4AA9-A5E1-5712DE6E914CQ38952142-4236A7E2-EC1B-4CA4-87E2-EC48F4452464Q38963197-615A5427-4F67-4461-B830-0E21523D822FQ39004331-A6D381DF-C0C5-4E29-8596-708E9DB6DB82Q39177912-EEFB1682-DBEC-4591-AF3D-8AECE9380F0EQ39201286-6B318C42-C942-46FD-BC24-68D3F91307E1Q39215730-22A4F648-99E3-4CE1-A22D-CD54018AAAF8Q39328213-51C9983B-1001-4CD0-99CF-394D3ACDA601Q39422223-A51F624F-EAB5-42A3-842F-F4D404304CF9Q40082981-031F2BA2-A6AB-47DB-84DE-986F06BF58B1Q40488679-158FA671-8F8B-4432-9FC8-3CA81052E152Q41451219-BD433481-229D-4BB8-9540-92958DC280ECQ41496727-283DA7C4-BDEB-4D69-96FC-00222F621E2DQ42177848-72EF6241-B035-4691-87C6-117BDEE9EC70Q42370926-1525406F-066A-4F67-A1E0-9E05BDDE8E48Q45875036-2B2B4680-190E-492C-8042-D4842C142834Q46403030-0618D626-72CD-4EC0-AD21-8289DD6E6654Q47163848-11C9C980-B3F2-4E0D-98DC-BC8B2DB64BF1Q47193905-599ED50A-21C0-4473-AEDB-E6A014C7F29DQ47286401-9BCAB176-E2A5-4948-97E2-9ACE8B1CC789Q47335254-251F1DDB-9A7D-45EE-9940-144E15FD93CAQ47576767-2D46057D-5648-4A61-B814-EFFD28A7F049Q47599705-9FC091F6-ADEA-410E-8612-72BE31B05786Q47656980-43B5FB92-26CD-4AD5-92FE-0D8F22C6F314Q47723607-A09DEFF7-540F-4EBD-AF6E-E1B1B7685490Q49790570-F4CEF478-049A-4A45-B47B-78E853B55B7CQ50083275-8C5FA105-5F1E-4D95-9DE5-D126A4BC11A8Q50093236-AFBD99EC-EA2D-44BD-BA17-9AF5BD3C1022Q50167027-06062C86-4687-4B47-9A8A-19F9AF18E1BFQ50945971-74243CC8-0568-4994-BD85-4801B85E7E5DQ52808829-2F9FB670-D1C6-4CD1-B556-49E76B6B091FQ55237166-B37362E8-23DE-4788-87E3-122241A18F5CQ55284758-C78FE3F5-16EA-430E-82E0-1A5BEC7F0517Q55316194-566687CF-4760-43FD-AE92-747670543FEDQ57646299-FFCF33E9-120E-4516-B076-DD740E5E3A73
P2860
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Proposal for a revised definit ...... dial and pericardial diseases.
@en
type
label
Proposal for a revised definit ...... dial and pericardial diseases.
@en
prefLabel
Proposal for a revised definit ...... dial and pericardial diseases.
@en
P2093
P2860
P50
P356
P1476
Proposal for a revised definit ...... dial and pericardial diseases.
@en
P2093
Alida L P Caforio
Aris Anastasakis
Denis Duboc
Eloisa Arbustini
Jens Mogensen
Jose L Zamorano
Juan Gimeno
Karin Klingel
Michael Böhm
Perry M Elliott
P2860
P304
P356
10.1093/EURHEARTJ/EHV727
P50
P577
2016-01-19T00:00:00Z